1-4 of 4
Andrew J. Brenner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer

Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman, Pavani Chalasani, Andrew J. Brenner, Alison Stopeck, Hannah Parris, Dexiang Gao, Tessa McSpadden, Jose Mayordomo, Jennifer R. Diamond, Peter Kabos, Virginia F. Borges
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (24): 5021–5030.
https://doi.org/10.1158/1078-0432.CCR-23-0117
Published: 15 December 2023
View article titled, Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer
Open the PDF for Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer in another window
Includes: Supplementary data
Journal Articles

ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

Priya Kumthekar, Shou-Ching Tang, Andrew J. Brenner, Santosh Kesari, David E. Piccioni, Carey Anders, Jose Carrillo, Pavani Chalasani, Peter Kabos, Shannon Puhalla, Katherine Tkaczuk, Agustin A. Garcia, Manmeet S. Ahluwalia, Jeffrey S. Wefel, Nehal Lakhani, Nuhad Ibrahim
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (12): 2789–2799.
https://doi.org/10.1158/1078-0432.CCR-19-3258
Published: 15 June 2020
View article titled, ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Open the PDF for ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases in another window
Journal Articles

Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression

Guang Chen, Xiao-Fei Ding, Kyle Pressley, Hakim Bouamar, Bingzhi Wang, Guixi Zheng, Larry E. Broome, Alia Nazarullah, Andrew J. Brenner, Virginia Kaklamani, Ismail Jatoi, Lu-Zhe Sun
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1486–1496.
https://doi.org/10.1158/1078-0432.CCR-19-2478
Published: 13 March 2020
View article titled, Everolimus Inhibits the Progression of Ductal Carcinoma <em>In Situ</em> to Invasive Breast Cancer Via Downregulation of MMP9 Expression
Open the PDF for Everolimus Inhibits the Progression of Ductal Carcinoma <em>In Situ</em> to Invasive Breast Cancer Via Downregulation of MMP9 Expression in another window
Includes: Supplementary data
Journal Articles

Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors

Andrew J. Brenner, Yael C. Cohen, Eyal Breitbart, Livnat Bangio, John Sarantopoulos, Francis J. Giles, Ernest C. Borden, Dror Harats, Pierre L. Triozzi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (14): 3996–4007.
https://doi.org/10.1158/1078-0432.CCR-12-2079
Published: 15 July 2013
View article titled, Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors in another window